Automated Behavioral Analysis of Large C. elegans Populations Using a Wide Field-of-view Tracking Platform.

Caenorhabditis elegans is a well-established animal model in biomedical research, widely employed in functional genomics and ageing studies. To assess the health and fitness of the animals under study, one typically relies on motility readouts, such as the measurement of the number of body bends or the speed of movement. These measurements usually involve manual counting, making it challenging to obtain good statistical significance, as time and labor constraints often limit the number of animals in each experiment to 25 or less. Since high statistical power is necessary to obtain reproducible results and limit false positive and negative results when weak phenotypic effects are investigated, efforts have recently been made to develop automated protocols focused on increasing the sensitivity of motility detection and multi-parametric behavioral profiling. In order to extend the limit of detection to the level needed to capture the small phenotypic changes that are often crucial in genetic studies and drug discovery, we describe here a technological development that enables the study of up to 5,000 individual animals simultaneously, increasing the statistical power of the measurements by about 1,000-fold compared to manual assays and about 100-fold compared to other available automated methods.

[1]  E. Nollen,et al.  Tryptophan metabolism: entering the field of aging and age-related pathologies. , 2013, Trends in molecular medicine.

[2]  Tuomas P. J. Knowles,et al.  Massively parallel C. elegans tracking provides multi-dimensional fingerprints for phenotypic discovery , 2018, Journal of Neuroscience Methods.

[3]  Michael O. Hengartner,et al.  Finding function in novel targets: C. elegans as a model organism , 2006, Nature Reviews Drug Discovery.

[4]  Renee M. Brielmann,et al.  Investigating the spreading and toxicity of prion-like proteins using the metazoan model organism C. elegans. , 2015, Journal of visualized experiments : JoVE.

[5]  I. Pe’er,et al.  Caenorhabditis elegans mutant allele identification by whole-genome sequencing , 2008, Nature Methods.

[6]  E. Mandelkow,et al.  Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity. , 2012, Human molecular genetics.

[7]  S. Lockery,et al.  An Image-Free Opto-Mechanical System for Creating Virtual Environments and Imaging Neuronal Activity in Freely Moving Caenorhabditis elegans , 2011, PloS one.

[8]  Tuomas P. J. Knowles,et al.  Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer’s disease , 2016, Proceedings of the National Academy of Sciences.

[9]  Rex A. Kerr,et al.  High-Throughput Behavioral Analysis in C. elegans , 2011, Nature Methods.

[10]  R. Kerr,et al.  Serotonin modulates locomotory behavior and coordinates egg-laying and movement in Caenorhabditis elegans. , 2001, Journal of neurobiology.

[11]  R. Morimoto,et al.  Destabilizing Protein Polymorphisms in the Genetic Background Direct Phenotypic Expression of Mutant SOD1 Toxicity , 2009, PLoS genetics.

[12]  David B Sattelle,et al.  Fast, automated measurement of nematode swimming (thrashing) without morphometry , 2009, BMC Neuroscience.

[13]  P. Oefner,et al.  Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation , 2012, Proceedings of the National Academy of Sciences.

[14]  Paul W. Sternberg,et al.  An imaging system for standardized quantitative analysis of C. elegans behavior , 2004, BMC Bioinformatics.

[15]  G. Lithgow,et al.  Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan , 2011, Nature.

[16]  Wagner Steuer Costa,et al.  Keeping track of worm trackers. , 2012, WormBook : the online review of C. elegans biology.

[17]  C. Link,et al.  Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity. , 2013, Drug discovery today. Technologies.

[18]  Michele Vendruscolo,et al.  Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method , 2017, Science Advances.

[19]  Dimitris N. Metaxas,et al.  CeleST: Computer Vision Software for Quantitative Analysis of C. elegans Swim Behavior Reveals Novel Features of Locomotion , 2014, PLoS Comput. Biol..

[20]  C. Link,et al.  Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Breitling,et al.  C. elegans Model Identifies Genetic Modifiers of α-Synuclein Inclusion Formation During Aging , 2008, PLoS genetics.

[22]  G. Ruvkun,et al.  A systematic RNAi screen for longevity genes in C. elegans. , 2005, Genes & development.

[23]  Hong Sun,et al.  Functional genomic approach to identify novel genes involved in the regulation of oxidative stress resistance and animal lifespan , 2007, Aging cell.

[24]  N. Munakata [Genetics of Caenorhabditis elegans]. , 1989, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[25]  Michele Vendruscolo,et al.  A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity , 2017, Proceedings of the National Academy of Sciences.

[26]  Walter Fontana,et al.  The Caenorhabditis elegans Lifespan Machine , 2013, Nature Methods.

[27]  Aravinthan D. T. Samuel,et al.  Optogenetic manipulation of neural activity in freely moving Caenorhabditis elegans , 2011, Nature Methods.

[28]  Zhao-Wen Wang,et al.  Track-A-Worm, An Open-Source System for Quantitative Assessment of C. elegans Locomotory and Bending Behavior , 2013, PloS one.

[29]  Richard I. Morimoto,et al.  The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Y. Christen,et al.  Amyloid-β-Induced Pathological Behaviors Are Suppressed by Ginkgo biloba Extract EGb 761 and Ginkgolides in Transgenic Caenorhabditis elegans , 2006, The Journal of Neuroscience.

[31]  Alejandro Chavez,et al.  Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Erik M. Jorgensen,et al.  The art and design of genetic screens: Caenorhabditis elegans , 2002, Nature Reviews Genetics.

[33]  Andrew G Fraser,et al.  Rates of Behavior and Aging Specified by Mitochondrial Function During Development , 2002, Science.

[34]  Dimitris N. Metaxas,et al.  A Novel Computational Approach for Simultaneous Tracking and Feature Extraction of C. elegans Populations in Fluid Environments , 2008, IEEE Transactions on Biomedical Engineering.

[35]  C. Dobson,et al.  Delivery of Native Proteins into C. elegans Using a Transduction Protocol Based on Lipid Vesicles , 2017, Scientific Reports.

[36]  Gary Ruvkun,et al.  DAF-16 Target Genes That Control C. elegans Life-Span and Metabolism , 2003, Science.

[37]  C. Masters,et al.  Utility of an improved model of amyloid-beta (Aβ1-42) toxicity in Caenorhabditis elegansfor drug screening for Alzheimer’s disease , 2012, Molecular Neurodegeneration.

[38]  Michael Petrascheck,et al.  Computational Analysis of Lifespan Experiment Reproducibility , 2017, bioRxiv.

[39]  C. Link,et al.  In Vivo Aggregation of β‐Amyloid Peptide Variants , 1998 .

[40]  Michele Vendruscolo,et al.  An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer’s disease , 2016, Science Advances.

[41]  Nektarios Tavernarakis,et al.  Nemo: a computational tool for analyzing nematode locomotion , 2007, BMC Neuroscience.

[42]  Matthew M. Crane,et al.  Real-time multimodal optical control of neurons and muscles in freely-behaving Caenorhabditis elegans , 2011, Nature Methods.

[43]  C. Link,et al.  A semi-automated motion-tracking analysis of locomotion speed in the C. elegans transgenics overexpressing beta-amyloid in neurons , 2014, Front. Genet..

[44]  Daniel Ramot,et al.  The Parallel Worm Tracker: A Platform for Measuring Average Speed and Drug-Induced Paralysis in Nematodes , 2008, PloS one.

[45]  D. Rubinsztein,et al.  Identification of MOAG-4/SERF as a Regulator of Age-Related Proteotoxicity , 2010, Cell.